Frohman, LP

April 2014LARRY P. FROHMAN, MD

HOME ADDRESS: 1 Berkeley RoadLivingston, NJ 07039

OFFICE ADDRESS: Institute of Ophthalmology and Visual ScienceDoctors Office CenterRutgers, New Jersey Medical School 90 Bergen Street, Suite 6100Newark, NJ 07103Telephone: 973-972-2026

1. EDUCATION

a. UNDERGRADUATESwarthmore College, Swarthmore, PA B.A. 9/1973 - 5/1976

b. GRADUATE AND PROFESSIONALUniversity of Pennsylvania School of Medicine, Philadelphia, PA M.D. 9/1976 - 5/1980

2. POSTDOCTORAL TRAINING

a.. INTERNSHIPS AND RESIDENCIES1. Internship - Presbyterian-University of Pennsylvania Medical Center, 51 North 39th Street,

Philadelphia, PA 19081, 7/1980 - 6/19812. Residency - New York University Medical Center- Bellevue Hospital, Department of

Ophthalmology, 550 First Avenue, NYC, NY 10016, 7/1981 - 6/1984

b. FELLOWSHIP1. Fellowship in Neuro-ophthalmology- New York University-Bellevue Medical Center, 550 First

Avenue, NYC, NY 10016, 1984-1985, Preceptor: Dr. Mark J. Kupersmith, Professor of Ophthalmology and Neurology, NYU Medical Center

3. MILITARY SERVICE None

4. LICENSURE1. New Jersey # 25MA04560600, 1985- Exp. 06/30/20152. New York # 146726 , 1981-2004 (opted for allowed inactive status after 2003)

5. CERTIFICATION: American Board of Ophthalmology, 1985

6. NARCOTICS CERTIFICATION1. NJ CDS D04119300 1985- Exp. 10/31/20132. DEA AF2145527 1982- Exp. 09/30/2015

1

Frohman, LP

7. UNIVERSITY APPOINTMENTS

New York University Medical CenterClinical Teaching Assistant in Ophthalmology, 1984-1985

Rutgers, - New Jersey Medical School (Formerly UMDNJ) Instructor in Ophthalmology, 1985-1986Assistant Professor of Ophthalmology & Neurosciences and Director of Neuro-ophthalmology, 1986-1991Associate Professor of Ophthalmology with tenure & Director of Neuro-ophthalmology, 1991-2006Professor of Ophthalmology with tenure and Director of Neuro-ophthalmology, 2006-presentVice Chair of Ophthalmology, 1991-presentAssociate Professor of Neurology & Neurosciences, 1993-2006Professor of Neurology & Neurosciences, 2006-presentActing Chair of Ophthalmology, 6/1993-1/1994Associate Director of Clinical Affairs, UMDNJ-New Jersey School, 1996-1998Director of Practice Development and Clinical Productivity, 2013

8. HOSPITAL APPOINTMENTS

Fellow/Attending in Ophthalmology, New York University Medical Center 1984-1985Attending in Ophthalmology, United Hospitals Medical Center, Newark, NJ 1985-1997Ophthalmology Consultant, Beth Israel Medical Center, Newark, NJ, 1985-1988Attending in Ophthalmology, University Hospital (UMDNJ-NJMS), 1985-presentAttending in Ophthalmology, East Orange Veteran's Administration Medical Center, 1985-1994,

Consultant, 1995-presentOphthalmology Consultant, St. Barnabas Medical Center, Livingston, NJ 1985-presentOphthalmology Consultant, Columbus Hospital, Newark, NJ, 1997-2002Ophthalmology Consultant, Overlook Hospital 1998-2008

9. PRINCIPAL CLINICAL AND HOSPITAL SERVICE RESPONSIBILITIES

University Hospital, Department of OphthalmologyChief, Neuro-ophthalmology, 1985-present

Responsible for supervising staffing and attending at Neuro-ophthalmology clinics and inpatient service/consults at University Hospital.

10. MAJOR ADMINISTRATIVE RESPONSIBILITIES

Department of Ophthalmology, responsible for administrating all aspects of Neuro-ophthalmology for Residency and affiliate hospitals, 1985-present

Department of Ophthalmology, major responsibility for administrating portion of residency selection process, general supervision of residency, and Departmental Administration, 1985-1993

Administration of New Jersey Medical School Faculty Practice Plan, 1988-present

Department of Ophthalmology, major responsibility for daily administration of DOC-OphthalmologyClinical Unit, 1992-1994

Vice Chair of Department of Ophthalmology, responsible for assisting and covering for Chair, 1992-present

2

Frohman, LP

MAJOR ADMINISTRATIVE RESPONSIBILITIES, cont…

Administration of NJMed, as one of the founders and officers, 1994-2003

Officer of Faculty Organization, responsible for its administration, 2000-2008

Senator, Faculty Senate UMDNJ), 2010 – 2013

President of Interim UMDNJ, Faculty Senate, 2011 – 2013

Senator, Rutgers Senate, 2013.

11. OTHER PROFESSIONAL POSITIONS AND MAJOR VISITING APPOINTMENTS

North American Neuro-ophthalmology SocietyParliamentarian, 1991-1993Vice President, 1996-2000Member, Executive Board, 1996-presentPresident- Elect, 2002-2004Chair, Education Committee, 2002-2004President, 2004-2006 Treasurer, 2008-2012 Board Chair, 2006-2008

Treas Executive Vice-President, 2010-present

American Academy of OphthalmologyChair, Continuing Medical Education/Self Assessment-Multimedia Subcommittee 1997- 2002. Alternate Councillor, 2001-2002

3

Frohman, LP

Chair, Panel on Establishing Curriculum in Neuro-ophthalmology (Knowledge Base Project), 2002-2009Councillor for Neuro-ophthalmology, 2003-2008

12. AWARDS AND HONORS

Tomorrow's Scientists and Engineer's Award, 1973Hannah Leedom Post-Graduate Fellowship at University of Pennsylvania School of Medicine (1976-1980)Hunter Grubb Post-Graduate Fellowship at University of Pennsylvania School of Medicine (1976-1980)Resident Education Award-NJMS Department of Ophthalmology, 1987Awarded New Jersey Medical School Teaching and Service Award, 1988Awarded New Jersey Medical School Teaching and Service Award, 1991Chosen as Session Organizer and Moderator, North American Neuro-ophthalmology Society, Park City, Utah, 2/1991Session Moderator, Frank Walsh Neuro-ophthalmology Society, Mar 13-14, 1993, New York, NY Session Organizer & Moderator, North American Neuro-ophthalmology Society, CO, March, 1994Best Doctors in America, Woodward White Press (published bi-annually), 1994-presentAmerican Academy of Ophthalmology Honor Award, 1995 The Best Doctors in America, American Health Magazine1 , 1996Award of Excellence in Education Award from American Association of Association Executives to American Academy of

Ophthalmology (AAO) for Provision CD-ROM concept developed by Drs. Frohman and Wisnicki for AAO, 1998Co-Chair, Neuro-ophthalmology Symposium/Free Paper Session, American Academy of Ophthalmology, New Orleans, LA,

1998AWARDS AND HONORS, cont…

Chosen Platform reviewer for “Pattern Visual Evoked Potential in the Diagnosis of Functional Visual Loss”, American Academy of Ophthalmology, Orlando, October, 1999

How to Find the Best Doctors: New York Metro Area, Castle Connolly Medical Press , 1998-2001Chosen Platform reviewer for “Chiari I Malformation Mimicking Pseudotumor Cerebri: neuroimaging and Treatment”,

American Academy of Ophthalmology, Dallas, October, 2000Marquis' Who's Who in America, 2000-presentBest Doctors in the Northeast, Woodward White Press, 1997Best Doctors in New Jersey, New Jersey Magazine, 1998, 2007Best Doctors in New York Area, New York Magazine, 1999, 2000, 2001, 2005-2012Who's Who in Medicine and Healthcare, 2002-2003 editionAmerican Academy of Ophthalmology Secretariat Award (first year given) for special contributions to education in

ophthalmology, 2002 American Academy of Ophthalmology, Senior Achievement Award, 2003American Academy of Ophthalmology, Secretariat Award for special contributions to education in ophthalmology, 2004Selected as program Co-Chair, Vascular Disease in Neuro-ophthalmology, NANOS Section at American Academy of

Ophthalmology, New Orleans, 2004Marquis Who's Who in the World, 2005 Best Doctors in America, database www.bestdoctors.com, 2005-2006Top Doctor, New Jersey Monthly Magazine, 2007Top Doctor: New York Metro Area, Castle Connolly Medical Ltd., 2001-2014Best Doctors in America, 2007-2008 database www.bestdoctors.com, 2007-2008Guide to America’s Top Ophthalmologists, Consumer Research Council of America, database

www.consumersresearchcncl.org, 2008, 2013Resident Education Award, The Institute of Ophthalmology & Visual Science, Newark, NJ, 2009Winner, Distinguished Service Award, North American Neuro-ophthalmology Society, 2010Chosen Session Moderator, Neuro-ophthalmology of Cancer, North American Neuro-ophthalmology Society Annual

Meeting, Tucson, AZ, March 10, 2010Top Doctor, Inside Jersey Magazine, Castle Connolly Medical Ltd., 2009-2012

1 Youngest ophthalmologist listed in US

4

Frohman, LP

Patients’ Choice Physician, Consumer Research, MDx Medical, Inc., 2011Faculty of the Year, NJMS, 2012Top Ophthalmologists, U.S. News & World Report, 2012

13. MEMBERSHIP ON BOARD OF DIRECTORS/TRUSTEES

Member, Board of Directors, North American Neuro-ophthalmology Society, 1996-present

Faculty Practice of New Jersey Medical School Member, Board of Directors, 1985-presentVice President 1988-1991

President 1992-1995, 2001-2010 Secretary 1996

Vice President, 1997-2000, 2011 - present

Member, Medical Advisory Board, Garden State Myasthenia Foundation, 1988-present

Vice President, Doctor's Center Management Corporation, 1992-present

Member, Board of Governors, New Jersey Academy of Ophthalmology, 1994-1996

Member, Board of Trustees, Eye Institute of New Jersey, 1993-2012Founding Executor, New Jersey Medical School Physicians Corporation, 1994-1995

5

Frohman, LP

MEMBERSHIP ON BOARD OF DIRECTORS/TRUSTEES, cont…

University Health Partnership-New Jersey Medical School Physicians Corporation, (NJMED)Board Member 1994-2005Vice President for Reimbursement and Board Vice Chair, 1995-7/1/98, 11/01-9/03Officer at Large 12/98-11/01

14. MAJOR COMMITTEE ASSIGNMENTS

a. INTERNATIONALChair, North American Neuro-ophthalmology Society Educational Slide Committee, 1991-1997 Practice Management Committee, North American Neuro-ophthalmology Society, Member, 1991

Co-Chair, 1993Chair, 1994-2000

Organizing Committee, North American Neuro-ophthalmology Society-Frank Walsh Society, Member, 1993

Member, Nominating Committee, North American Neuro-ophthalmology Society, 1999, 2005, 2010-presentMember, Web-based Education Subcommittee, North American Neuro-ophthalmology Society,

2000-2008Chair, Long Range Planning Committee, North American Neuro-ophthalmology Society, 2000-2002Member, Education Committee, North American Neuro-ophthalmology Society, 2000- Chair, 2002-2004Scientific Program Subcommittee, North American Neuro-ophthalmology Society, Member, 2002Chair, 2002-2004Member, NANOS ICD-11 Taskforce, North American Neuro-Ophthalmology Society, 2010-presentMember, Finance, Development, NOVEL, Practice Management Committee, NANOS, 2012

b. NATIONAL AND REGIONAL Member, New Jersey State Board of Medical Examiners Medical Expert Advisory Panel, 1993Member, Board of Governors, New Jersey Academy of Ophthalmology 1994-1995Member, Managed Care Advocacy Committee, American Academy of Ophthalmology 1994-1996Member, Continuing Education/Self Assessment Committee, American Academy of Ophthalmology, 1995-2002Chair, Subcommittee on Multimedia Continuing Education Products, American Academy of Ophthalmology, 1996-

2002Member, Electronic Compendium of Ophthalmic Knowledge Steering Committee, American Academy of

Ophthalmology, 1999-2000Member, Clinical Education Planning Group, American Academy of Ophthalmology, 1999-2001Associate Councillor, American Academy of Ophthalmology, 2002-2003Chair, Clinical Knowledge Panel in Neuro-ophthalmology, American Academy of Ophthalmology, 2002-presentMember, Media Advisory Task Force, American Academy of Ophthalmology, 2002 - presentCouncillor, American Academy of Ophthalmology, 2003-2008Northeast Regional Chair, Council, American Academy of Ophthalmology, 2004Member, Council Task Force on the Subspecialty Certification, American Academy of Ophthalmology, 2004-2008Deputy Chief of Council, American Academy of Ophthalmology, 2008-9

c. MEDICAL SCHOOL Member, Top 25 Faculty Committee, 1988Member, Medical Office Building Committee, 1988-1991Member, NJMS LCME Review Finance Committee, 1989Member, NJMS-Doctor's Office Center Clinical Practice Committee, 1989Member, Ophthalmology Search Committee, 1991-1993Member, NJMS Strategic Planning Committee 1993, 2000Member, UMDNJ Advisory Committee to University Health Care Corporation, 1994

6

Frohman, LP

MEDICAL SCHOOL, cont…

Member, UMDNJ Strategic Planning Task Force on Health Care, 1994Member, University Strategic Planning Committee 1994-1995Member, Medical School Salary Structure Committee, 1996Member, Joint Contracting/Physicians Hospital Organization Committee, 1997Faculty Organization,

Secretary-Treasurer 2000-2002, 2004-2005Vice president 2003-2004President 2005-2008

Member, Steering Committee, PRIME Task Force, NJMS, 2001-2002Member, Institutional Planning and Development Committee, NJMS, 2001-2010Member, NJMS Bylaws Committee 2002-2010

Chair 2009-2010Member, Faculty Committee on Appointments and Promotions 2003-2005Chair, LCME Governance Subcommittee 2004-2005Member, LCME Committee, 2004-2005Member, Neuroscience Chair Search Committee, 2006-2010Member, Dean Search Committee, 07/01/2008-06/30/2009Member, Clinical Planning Committee, 2008-2010Chair, NJMS Bylaws Committee, 2008-2009

Member, NJMS Bylaws Committee, 2009-2010Member, UMDNJ Faculty Development Senate Committee, 2009-2011Member, Neurology Chair Search Committee, 2009-2010Member, Joint UPA-NJMS Communications Committee, 2009-presentMember, Joint UPA- NJMS Strategic Planning Committee, 2009-presentMember, UMDNJ Financial RoadMap Task Force, Team 4-Revenue Enhancement, 2010-2011

Member, Neurosurgery Chair Search Committee, 2010-2011Acting Chair, Neurosurgery Chair Search Committee, 2011NJMS Faculty Senator, 2011-2013Member, UMDNJ Board Committee on UMDNJ Realignment, 2011First President, UMDNJ Faculty Senate, 2011-2013

Chair, Blue Sky Committee, 2011-2012Member, Strategic Planning – NJMS Faculty Practice Committee, 2011-presentCofounder & Co-Director, NJMS Sarcoidosis Center, 2012-presentMember, Rutgers University Senate, July 02, 2013. Chair, Committee to form Rutgers Biomedical Health Science Faculty Organization, 2013-

d. HOSPITALMember, Executive Committee, Newark Eye and Ear Infirmary, 1988-1990Member, Medical Executive Committee, University Hospital, 1992-presentMember, Medical Executive Committee Governing Council (Officers) 1995-Member, Orbital and Facial Trauma Committee, University Hospital, 1992-2003Member, Managed Care Consultant Committee, University Hospital, 1993-2004Member, Business Plan Committee, University Hospital, 1996Member, Master Space Planning Committee, University Hospital, 1996Member, Strategic Work Group- Managed Care, 2000-2003Member, Ambulatory Care Committee 2000-2003Member, Bylaws Committee, 2003-2010Member, Medical Records Committee, 2007-presentMember, Epic Ambulatory Committee, 2008-Member, Chief Executive Officer Search Committee, 2009Member, Strategic Planning & Development Committee, 2009-2011Member, Nominating Committee, 2011-present

7

Frohman, LP

MAJOR COMMITTEE ASSIGNMENTS, cont...

Member, Bylaws Committee, 2011-presentMember, UH/UMDNJ/UPA Task Force on Charity Care, 2011-presentMember, Epic inpatient implementation committee, 2013

e. DEPARTMENTMember, Medical Education Committee, 1985-presentMember, Residency Selection Committee, 1985-2001, 2004-present (Chairman, 1987-1994)Associate Director of Medical Education, 1987-1994Chair, Faculty Recruitment Committee, 1991-1994Member, Executive Committee, 1992-1994

f. EDITORIAL BOARDSSection Editor, Systemic Diseases, Journal of Neuro-ophthalmology, 1996-2001Editorial Advisory Board, American Academy of Ophthalmology EyeNet Magazine, 2002-2008

g. AD HOC REVIEWERReviewer, Neuro-ophthalmologyReviewer, Journal of Allergy and Clinical ImmunologyReviewer, Journal of Neuro-ophthalmologyReviewer, Archives of OphthalmologyReviewer, OphthalmologyReviewer, American Journal of OphthalmologyReviewer, Survey of OphthalmologyReviewer, British Journal of OphthalmologyReviewer, BrainReviewer, Journal of Ocular Immunology and InflammationReviewer, Eye,

h. UNIVERSITY PHYSICIANS ASSOCIATESMember, Faculty Practice Board (UPA), 1985-present

Vice President 1988-1991 President 1992-1995, 2001-2010 Secretary 1996

Vice President, 1997-2000, 2011-2012Faculty Practice Board Review Committee, Member, 1986-1989, 1996

Chair, 1988-1989 and 1996Member, Faculty Practice Board Finance Committee, 1987, 2011-presentChair, UPA Bylaws Committee, 1989-2000, 2011-presentMember, UPA Capital Equipment Committee, 1991Member, UPA ByLaws Committee, 2009-present, Chair 2011-presentMember, UPA Finance Committee, 2011-presentMember, Reimbursement/Contracting Committee, 2009-present

8

Frohman, LP

15. MEMBERSHIP, OFFICES, AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES

Member, Sigma Xi, 1975-present

Member, American Medical Association, 1977-present

American Academy of OphthalmologyMember, 1982-presentMember, Self Assessment Committee 1995-2002Chair, Multimedia Education Subcommittee 1996-2002Media Spokesperson, 2000-presentChair, Clinical Knowledge Panel, Section on Neuro-ophthalmology/Orbit, 2002-2009Associate Councillor, 2002Councillor, 2003-2008Northeast Regional Chair, Council, American Academy of Ophthalmology, 2004Member, Council Section Nominating Committee, 2006Deputy Section Leader, Council, American Academy of Ophthalmology, 2007

Member, The Association for Research in Vision and Ophthalmology (ARVO), 1988-present

Member, Medical Leadership Council, The Advisory Board Company, 1996-1997

North American Neuro-Ophthalmology SocietyMember 1989-present Member, Board of Trustees 1996-present Vice President 1996-2000President Elect 2002-2004President 2004-2006Chair, Board or Trustees 2006-2008Treasurer, 2008-2012Executive Vice President, 2011-presentChair, Managed Care Committee 1993-2000Member, Bylaws Committee 1996Chair, Long Range Planning Committee 2000-2001Member, Education Committee 2000-2008Chair, Education Committee 2002-2004Chair, Nominating Committee 2006-2010Member, NANOS ICD-11 Taskforce 2010-presentMember, Long Range Planning Committee, 2011-2

16. MAJOR RESEARCH INTERESTS

My overall interest is in unexplained visual loss/symptomatology caused by undetected or unknown systemic disease, such as vasculitis, autoimmune diseases, and sarcoidosis. We have published papers on diagnosing autoimmune optic neuropathy, on how to detect occult sarcoidosis presenting as neuro-ophthalmic disease, and on neuro-ophthalmic signs of vasculitis. I have also published on treatment strategies for these entities, including the first use of thalidomide for neurosarcoid (Celgene- Federal Drug Administration, Compassionate Use of Thalidomide for Neurosarcoid, 1998, IND 55,321).

The other area of interest has been educational techniques in ophthalmology. I have, with Dr. Jay Wisnicki, developed the patient simulation paradigm that was used in the American Academy of Ophthalmology’s ProVision interactive CD series, as well as chaired their development of web-based simulations. I am one of three grantees on the NOVEL (Neuro-ophthalmology Virtual Education Library) project funded by the National Library of Medicine. In this project, we are linking educational assets (videos, audio lectures, still images, PowerPoint lectures...) to a core curriculum that we have developed at the North American Neuro-ophthalmology Society (NANOS).

9

Frohman, LP

17. GRANT HISTORY

a. Principal Investigator1. Foundation of UMDNJ - 1/1986-12/1986, direct costs = $15,340, total = $15,340.2. Fund for the New Jersey Blind- A New Optical Device for the Evaluation of Optic

Neuropathies 1/1987-12/1987, direct costs = $12,000, total = $12,000.3. Lions Sight Foundation- (Co-Principal Investigator) , Optic Neuritis and Auto Antibodies,

1/1988-12/1988, direct costs = $3,500, total = $3,500.4. Sandoz Pharmaceuticals- Educational grant: Symposium on Immunologic Disease of

the Eye. (Co-Principal Investigator), 5/1989, direct costs = $25,000, total = $25,000.5. National Society to Prevent Blindness - Fight for Sight, Inc. Autoantibodies in Optic

Neuritis, 7/1990-9/1992, direct costs = $12,000, total = $12,000.6. Eye Institute of New Jersey, post-doctoral support for Dr. Z. Dong, Immuno-

Ophthalmology Center, (Co-Principal Investigator) 1990-1991, $13,000.7. Lions Eye Research Foundation of NJ, Optic Nerve Autoantibodies Optic Nerve, 7/1/1990-6/30/1991,

direct costs = $16,000, total = $16,000.

10

Frohman, LP

8. Fund for the New Jersey Blind, Autoantibodies in Optic Neuritis. (Co-Principal Investigator),-7/1990-06/1991, direct costs = $10,243, total = $10,243.

9. The Goldring Family Foundation, unrestricted, 2000, direct costs = $2,500, total = $2,500.10. Study of a Topical Agent for Ischemic Optic Neuropathy, Allergan, 2000 (multicentered trial, approximately

$82,000 at NJMS- study halted in recruitment).11. Use of Retrospective Chart Review to Determine the Proper Therapies of Two Unusual Subsets of Two

Common Neuro-ophthalmic Conditions: Pseudotumor Cerebri in Pregnancy and Traumatic Optic Neuropathy in the Comatose Patient. Eye Institute of New Jersey, 2001, direct costs = $15,000, total = $15,000.

12. Fight for Sight, Inc. - Raynaud’s Disease as a Risk Factor for Non-Arteritic Ischemic Optic Neuropathy, 09/2001-08/2002, direct costs = $20,000, total = $20,000.

13. Development of a Portable Computerized Video Device to allow those with hemifield defects to see their blind hemifield Source. Fund for the New Jersey Blind, 12/10/2001, direct costs = $5,000, total = $5,000.

14. Establishment of normal values on automated kinetic perimetry in children. Haag Streit, 2003, direct costs = $8,644, total = $8,644.

15. Development of Patient Simulations in Ophthalmology for Medical Students and Primary Care Physicians to Supplement Standard Curriculum. UMDNJ Educational Technology Grant, 2004, direct costs = $15,000, total = $15,000.

16. Neuro-ophthalmology Virtual Education Library (NOVEL). Awarded to the North American Neuro-ophthalmology Society, Frohman LP (PI). Pfizer, Inc., 01/01/2008-12/31/2008, direct costs = $80,000, total = $80,000.

17. Neuro-ophthalmology Research Disease Investigators’ Consortium (NORDIC), Site PI – Idiopathic Intracranial Hypertension Treatment Trial, funded by NEI through NORDIC, 2010 - $9,629 per patient plus start up costs.

b. Co - Investigator1. Fund for the New Jersey Blind, Use of a Variable Neutral Density Filter for the Evaluation of Afferent

Pupillary Defects in Amblyopia. R. Wagner, P.I., 1/1987-12/1987, direct costs = $5,750, total = $5,750.2. Co-investigator, Fight for Sight, Inc. PD#022-88, L. Bielory-P.I., 7/01/1988-06/30/1989, direct costs =

$12,000, total = $12,000.3. Fund for the New Jersey Blind. Autoantibodies in Optic Neuritis. L. Bielory (P.I.) 1/1988-12/1988, direct

costs = $2,239, total = $2,239.4. Fund for the New Jersey Blind, Immunology of Tears. L. Bielory (P.I.) 1/1989-12/1989,

direct costs = $4,133, total = $4,133.

11

Frohman, LP

GRANT HISTORY, cont…Co – Investigator, cont…

5. Sandoz Pharmaceuticals, Educational Grant, Symposium on Uses of Cyclosporine. L. Bielory (P.I.)., 01/1991-11/1991, direct costs = $13,500, total = $13,500.

6. Lions Eye Research Foundation of New Jersey, Immunological Analysis of Tears. L. Bielory ( P.I.), 10/1990-09/1991, direct costs = $22,135, total = $22,135.

7. Foundation of UMDNJ, Immunologic Analysis of Tears in Corneal Transplants, L. Bielory (P.I..), 1/1991-12/1991, direct costs = $21,087, total = $21,087.

8. Biogen, A Randomized Double-Blind, Placebo-Controlled Study of Avonex (Interferon Beta-1a) in the Treatment of Subjects at High Risk for Development of Multiple Sclerosis Following the First Onset of an Isolated Demyelinating Event. Stuart Cook (P.I.), CHAMPS Study, 1996, direct costs = 19,897, total = $24,872.

9. National Library of Medicine, Neuro-ophthalmology Virtual Education Library (NOVEL). N. Lombardo (P.I.), University of Utah, 2003-2006, direct costs = $433,739, total = $433,739.

10. Web-based Ocular Imaging Library and Credentialing Program for Improvement of Ophthalmology Education. Suqin Guo (P.I.), UMDNJ Educational Technology Grant, 2004, direct costs = $15,000, total = $15,000.

11. Acetelion MS Study AC58B201 NORDIC. S. Kamin (P.I.), UMDNJ-NJMS Department of Neurology, direct costs = $64,015 , total = $80,907

c. Sponsor1. Cohen, Avi, MS-4 (Albert Einstein) Sigma Xi, Optic Neuritis and Autoantibodies, 6/1989-9/1989, $900. 2. Lucca, John, MS-4 (UMDNJ-NJMS) Sigma Xi, Keratoconjunctivitis Sicca in Human Immunodeficiency

Virus Infections, 6/1989-12/1989, $1,000.3. Fucigna, Robert, MS-4, (UMDNJ-NJMS), Fight for Sight, Immunologic Tear Assays, 6/90-9/90, $1,000.4. Fucigna, Robert, MS-4, (UMDNJ-NJMS), Sigma Xi, Immunologic Tear Assays, 6/90-9/90, $850.5. Wilkerson, Mark, MS-2, (UMDNJ-NJMS), National Academy of Science-Sigma Xi, Immunology of Tears

6/1991-9/1991, $1,087.6. Pan, Lawrence, MS-2 (UMDNJ-NJMS) 2004 Summer Student Program, Does Lacrimal Gland Size Matter in

Differentiating Sarcoid versus Typical Optic Neuritis, 2004.

18. MAJOR TEACHING EXPERIENCE

a. Lectures Annual lecture program in neuro-ophthalmology to NJMS Ophthalmology training programScheduled as 12 hours lectures per year, plus 5 hours of clinical conferences per year.

In several past years, lectured to first-year students in Anatomy on ophthalmology, and from about 1986-1994 lectured to third -year students in small session tutorial in neuro-ophthalmology (90 minutes every other week)

Also lectures about 1-2 hours per year to Allergy and Immunology Fellowship program.

b. Research Training1. Postdoctoral Fellows - None2. Predoctoral Students - None

12

Frohman, LP

MAJOR TEACHING EXPERIENCE, cont…

c. InstructionMajor responsibility for AAO multi-media based education 1996-2002

Chair , North American Neuro-ophthalmology Society Education Committee, responsible for annual meeting content and all CME activities of society 2002-2004

Chair, Clinical Knowledge Panel, Section on Neuro-ophthalmology/Orbit American Academy of Ophthalmology 2002- 2008- Established curriculum for American Board of Ophthalmology recertification process

Selected to teach Neuro-ophthalmology/Orbit Section of first American Academy of Ophthalmology Course on Knowledge Base Curriculum, Chicago, IL, for Recertification, 2006

19. PRIVATE PRACTICE

The Eye Institute of New Jersey15 South Ninth StreetNewark, NJ 07107 1985-1992

Institute of Ophthalmology and Visual ScienceDoctors Office CenterRutgers, New Jersey Medical SchoolUniversity Ophthalmology Associates90 Bergen Street, Suite 6100Newark, NJ 07101-1709 1992-present973 972-2065

My private practice in neuro-ophthalmology is located at Institute of Ophthalmology & Visual Science, Rutgers –NJMS (formerly UMDNJ), entirely through auspices of NJMS-Faculty Practice (UPA), 1985-present. Our satellite office is located in Roseland, NJ. It is a referral-based practice serving several states.

University Ophthalmology Associates556 Eagle Rock Avenue

1995-present973 972-2108

13

Frohman, LP

20. ARTICLES

1. Frohman, LP., Epstein, Fred, and Kupersmith, Mark. Atypical Visual Prognosis with an Optic Nerve Glioma. J Clin Neuro-ophthalmol 5:90-4, 1985.

2. Frohman, LP. and Kupersmith, Mark. J. Reversible Vertical Deviations Associated with Raised Intracranial Pressure. J Clin Neuro-ophthalmol 5:158-163, 1985.

3. Frohman, LP., Kupersmith, Mark, Lang, J.L., Bergeron, R.T., Reede, D.L., Aleksic, Slobodan, and Trasi, S. Pseudotumor of the Orbit with Bone Destruction and IntracranialExtension. Arch Ophthalmol 104:380-4, 1986.

4. Wagner, Rudolph S., Caputo, Anthony R., and Frohman, LP. Congenital Unilateral Adduction Deficit with Simultaneous Abduction: A Variant of Duane's Syndrome. Ophthalmol 94:1049-1053,1987.

5. Frohman, L.P., Klug, R., Bielory, L., Patti, J.C., and Noble, K. Acute Posterior Multifocal Placoid Pigment Epitheliopathy with Unilateral Retinal Lesions and Bilateral Disc Edema. Am J Ophthalmol 104:548-550,1987.

6. Frohman, Larry P., Pinto, Richard, Warren, Floyd, and Kupersmith, Mark J. Metrizamide Computed Tomographic Cisternography: A High-Yield Diagnostic Procedure for Chiasmal Syndromes with Equivocal Computed Tomographic or Magnetic Resonance Scans. Neuro-ophthalmol 7:251-266,19872.

7. Kupersmith, M.J., Frohman, L.P., Choi, I.S., Foo, S.H., Hiesinger, E., Berenstein, A., Wise, A., Carr, R.E., and Ransohoff, J. Visual System Toxicity Following Intraarterial Chemotherapy. Neurology 38: 284-289,1988.

8. Bielory, L, Holland, C, Gascon, P, and Frohman, L. Uveitis, Cutaneous, and Neurosarcoid: Treatment with Low-Dose Cyclosporine A. Transplantation Proceedings: 20(3): June, 1988.

9. Kupersmith, MJ, Burde, R, Warren, F, Klingele, TG, Frohman, LP, and Mitnick, H. Autoimmune Optic Neuropathy: Evaluation and Treatment. J Neurol Neurosurg and Psych 51:1381-86, 1988.

10. Wagner, RS and Frohman, LP. Long term results: Botulinum for sixth nerve palsy. J Ped Ophthalmol and Strabismus, 26:106-8, 1989.

11. Bielory, L, Ogunkoya, O, and Frohman, LP. Temporal Arteritis in Blacks. Am J Med 86:707-708, 1989.12. Bielory, LB, Conti, J, and Frohman, LP. Cogan's Syndrome. J Allergy Clin Immunology, 85: 808-815, 1990.13. DeRespinis, R and Frohman, LP. Microwave Popcorn-Ocular Injury Caused by Steam.

NEJM 323:1212,19903.14. Frohman, LP, Warren, F, and Kupersmith, MJK. The pituitary incidenteloma beyond the first year of follow-up.

JAMA 264:2387,1990.15. Bielory, LB, Cohen, A, and Frohman, LP. Migraines, spontaneous abortions, central nervous system involvement and a

positive VDRL in a 36-year-old white female. Ann Allergy, 65:447-453, 1990.16. Frohman LP, Joshi VV, Wagner RS, Bielory L. Pseudotumor cerebri as a cardinal sign of the polyangiitis overlap

syndrome. Neuro-ophthalmol 11:337-345,19912.

17. Bielory, L, Noble, K, and Frohman, L. Urticarial vasculitis and visual loss. J Allergy Clin Immunology, 88:819-821,1991.

18. Frohman LP, Cook S, Bielory L. Dysgammaglobulinemia in Steroid Dependent Optic Neuritis. J Clin Neuro-ophthalmol 11:241-245, 1991.

19. Bielory L and Frohman, LP. Low Dose Cyclosporine A Therapy of Granulomatous Optic Neuropathy and Orbitopathy. Ophthalmol 98:1732-1736, 1991.

20. Mauriello J, Schulder M, Krieger A, DeLuca J, and Frohman, L. Management of Traumatic Optic Neuropathy-A Study of 23 Patients. Br J Ophthalmol 1992; 76:349-352..

21. Bielory L and Frohman LP. Allergic and Immunologic Disorders of the Eye. J Allergy Clin Immunol 1992; 861-15.22. Haupt E, Katz R, Chin P, Cinotti, AA, and Frohman L. Distinct Patterns of Spatial Frequency Response by Normal,

Recovered Optic Neuritis, and Normal Fellow Eyes to a New Linearly Variable Neutral Density Device. Von Graefe's Arch 1993; 231:79-83.

23. Bielory L, Kupersmith MJ, Warren F, Bystryn JC, and Frohman LP. Skin Biopsies in the Evaluation of Atypical Optic Neuropathies. Ocular Immunology and Inflammation, 1:231-241, 19934.

2This European journal was not at that time in Index Medicus3This letter does not appear in Index Medicus4This article was placed in the initial volume of this journal; first year does not appear in Index Medicus.

14

Frohman, LP

ARTICLES, cont...

24. Frohman, Larry, Warren, Floyd. Myasthenia Gravis by Another Name:An Elusive Imposter (Clinical Challenge) Surv Ophthalmol 38:219-226, 19935.

25. Mauriello JA, Shaderofsky P, Gizzi M, Frohman L. Management of Visual Loss after Optic Nerve Sheath Decompression in Patients with Pseudotumor Cerebri. Ophthalmol 1995; 102:441-445.

26. Vargas, Marino, Kupersmith, Mark, Savino, Peter, Petito, Frank, Frohman, Larry, and Warren, Floyd. Homonymous Field Defect as the First Manifestation of Creutzfeldt-Jakob Disease. Am J Ophthalmol 1995; 497-504.

27. Bielory Leonard and Frohman Larry. UMDNJ and Managed Care. New Jersey Medicine. 1995;92:651-654.28. Galati Lisa, Baredes Soly, Mauriello Joseph, and Frohman Larry. Visual Loss Reversed after Treatment of Acute

Bacterial Sinusitis. Laryngoscope 1996;106:148-151.29. Wolansky Leo J, Rao Satyaveni B, Schulder Michael, Elias Brad, Brautigan Rob, Choudri Ajay, Kalnin, Andrew J,

Frohman, Larry P, and Lee Huey-Jen. Extrasellar Extension of Pituitary Lesions. Comparison of T2-Weighted Fast Spin Echo MRI with T1-Weighted Sequences. Intl J Neuroradiology 1996; 2:147-152.

30. Wolansky LJ, Shaderowfsky PD, Sander R, Frohman LP, Kalnin AJ, Lee HJ. Optic Chiasmal Compression by Venous Aneurysm: Magnetic Resonance Imaging Diagnosis. J Neuroimaging 1997; 7:46-7.

31. Barchuk William T, Centeno Ligaya, Frohman Larry, and Bielory William. Immunology and Ocular Manifestations of Giant cell Arteritis. Ocular Immunology and Inflammation, 1997; 5:141-145.

32. Frohman, Larry, Wolanski, Leo. Magnetic Resonance Imaging of Syphilitic Optic Neuritis/ Perineuritis. J Neuro-ophthalmol 1997:17:57-9.

33. Kupersmith Mark J, Frohman Larry, Sanderson Matthew, Jacobs Jennifer, Hirschfield James, Ku Christie, and Warren Floyd. Aspirin Reduces the Incidence of Second Eye NAION: A Retrospective Study. J Neuro-Ophthalmol 1997:17:250-253.

34. Frohman Larry and Lama Paul. Systemic Diseases-Annual Review, 1996. J Neuro-ophthalmol 1998:18:67-79.35. Lama Paul and Frohman Larry. Systemic Diseases-Annual Review, 1997. J Neuro-ophthalmol 1998:18:127-142.36. Bennett JL, Galetta SL, Frohman LP, Mourelatos SD, Gultekin SH, Dalmau JO, and Posner, JB. Neuro-ophthalmic

Manifestations of a Paraneoplastic Syndrome and Testicular Carcinoma. Neurology 1999:52:864-867,37. Frohman LP and Bielory L. Not So Slowly progressive Visual Loss (Syphilitic Optic Neuropathy- Clinical Challenge

Discussion) Surv Ophthalmol 1999:44(3) 247-252. 38. Frohman LP and Lama P. Annual Update of Systemic Disease--1999: Emerging and Re-emerging Infections (Part I). J

Neuro-ophthalmol 19(4):263-73, 1999.39. Frohman LP, Burg S. Interactive Ophthalmic Education: Learning for the Future. Ophthalmology Clinics of North

America 13:279-287, 2000.40. Frohman L. Lama P. Annual update of systemic disease--1999: emerging and re-emerging

infections (Part II). J Neuro-ophthalmol 20(1):48-58, 2000.41. Frohman, LP. Discussion of Xu Shizhao, Meyer David, Matthews Dennis, and Yoser Seth. “Pattern Evoked Potential

in the Diagnosis of Functional Visual Loss.” Ophthalmol 108; 2001:80-82.42. Frohman L, Frieman B, Wolansky L. Reversible blindness due to optic chiasmitis secondary to systemic lupus

erythematosus. J Neuro-ophthalmol 21:18-21, 2001.43. Frohman, LP, Grigorian R, Slamovits T. Evolution of Sarcoid Granulomas of the Retina. Am J Ophthalmol 131:661-

2, 2001.44. Frohman L. Systemic Disease and Neuro-Ophthalmology: Annual Update 2000 (Part II) J Neuro-ophthalmol 12:74-

82, 2001.45. Frohman L, Grigorian R, Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and

management. J Neuro-ophthalmol 21:132-137, 2001.46. Dinowitz M, Leen JS, Hameed M, Wolansky L, Frohman L. Sudden painless visual loss in an adult. Surv Ophthalmol

46(2):143-8, 2001 Sep-Oct. 47. Vaphiades MS, Eggenberger ER, Miller NR, Frohman L, Krisht A. Resolution of Papilledema after Neurosurgical

Decompression for Primary Chiari I malformation. Am J Ophthalmol 2002; 133:673-678.

5Clinical Challenges in Survey of Ophthalmology does not get indexed under the name of the physician who writes the discussion.

15

Frohman, LP

ARTICLES, cont...

48. Turbin RE, Khoobiar SA, Langer P, Amesur K, Frohman LP, Warren F, Baredes S,Kennerdell JS. Adjuvant Therapy for Invasive Sino-orbital Fungal Infection Conjunctiva. J Neuroophthalmol 2002 June; 22(2):178-9.

49. Frohman L, Turbin R, Bielory L, Wolansky L, Lambert WC, Cook S. Autoimmune optic neuropathy with anticardiolipin antibody mimicking multiple sclerosis in a child. Am J Ophthalmol 2003 Aug;136(2):358-60.

50. Frohman LP, Guirgis M, Turbin RE, Bielory L. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol 2003 Sep;23(3):190-7.

51. Schickner DC, Yarkoni A, Langer P, Frohman L, Chen X, Folberg R, and Del Priore LV. Panophthalmitis due to Clostridium septicum. Am J Ophthalmol 137(5) 942-944, 2004.

52. Cohen A, Kishore K, Wolansky L, and Frohman LP. Pituitary apoplexy occurring during large volume liposuction surgery. J Neuro-ophthalmol 24:31-33, 2004.

53. Frohman L, Digre K. Ophthalmic subspecialty fellowship accreditation and ophthalmic subspecialty certification: still hot issues. J Neuro-ophthalmol 2004; 24:94.

54. Digre K and Frohman L. Neuro-ophthalmology Virtual Library (NOVEL) J Neuro-ophthalmol 2004; 24:91.55. Lee H, Jilani M, Frohman L, Baker S. CT of Orbital Trauma. Emergency Radiology 10:168-172, 2004. 56. Behbehani R,Sergott RC, Frohman LP. Foggy Vision (Clinical Challenge)6 Surv Ophthalmol 2005; 50(3):231-96.57. Frohman LP. How Can We Assure That Neuro-ophthalmology Will Survive? (Editorial) Ophthalmol 2005;

112(5):741-50.58. Cuadra S, Padberg F, Turbin RE, Farkas J, and Frohman, LP. Cerebral venous hypertension and blindness: A

reversible complication. J Vasc Surg 2005; 42(4):792-5.59. Frohman L. The approach to bilateral simultaneous isolated optic neuritis. [Editorial] Br J Ophthalmol 2006;

90(5):526-7.60. Mathews M, Savino P, Lee H-J, Frohman L, Sergott R. Spinal fluid leak after chiropractic manipulation of the spine.

Arch Ophthalmol 2006; 124:283.61. Chung JH, Van Stavern GP, Frohman L, Turbin RE. Adalimumab-associated optic neuritis. J Neurologic Sci 2006;

244:133-6.62. Turbin RE, Wladis EJ, Frohman LP, Langer PD, Kennerdell JS. A role for surgery as adjuvant therapy in optic nerve

sheath meningioma. Ophthal Plast Reconstr Surg 2006; 22(4):278-82. 63. Shinder R, Frohman LP, Turbin RE. Regression of bilateral optic disc edema after discontinuation of amiodarone. J

Neuro-ophthalmol 2006; 26(3):192-4.64. Turbin RE, Maxwell DN, Langer PD, Frohman LP, Hubbi B, Wolansky L, Mori M. Patterns of transorbital

intracranial injury: a review and comparison of occult and non-occult cases. Surv Ophthalmol 2006; 51(5):449-60.65. Hosler MR, Turbin RE, Cho ES, Wolansky LJ, Frohman LP. Idiopathic hypertrophic pachymeningitis mimicking

lymphoplasmacyte-rich meningioma. J Neuro-Ophthalmol 2007; 27(2): 95-8.66. Digre KB, Lombardo NT, Frohman LP. The neuro-ophthalmology virtual education library (NOVEL). Neuro-

Ophthalmol 2007; 31:175-8.67. Zamecki KJ, Frohman LP, Turbin RE. Severe visual loss associated with idiopathic intracranial hypertension (IIH)

in pregnancy. Clin Ophthalmol 2007; 1(2): 99-103.68. Tannen BL, Ghesani N, Frohman LP, Eichler J, Maldjian P, Chu DS. Use of whole-body FDG PET-CT to aid in

the diagnosis of occult sarcoidosis. Ocular Immunol Inflamm 2008; 16(1-2):25-7.69. Frohman LP. The human resource crisis in Neuro-ophthalmology. J Neuro-Ophthalmol 2008; 28(3):231-4.70. Digre K, Lombardo N, Frohman LP, Friedman D. Upgrades in the neuro-ophthalmology virtual education library

(NOVEL). J Neuro-Ophthalmol 2008; 28(3):253-4.71. Frohman LP, Della Torre K, Turbin R, Bielory L. Clinical characteristics, diagnostic criteria, and therapeutic outcomes

in autoimmune optic neuropathy. Br J Ophthalmol 2009; 93(12):1660-6.72. Elmalen VI, Younge BR, Biousse V, Leavitt JA, Moster ML, Warner J, Kupersmith MJ, Landau K, Brodsky MC,

Frohman LP, May ER Tomsak RL, Newman NJ. Clinical course and prognosis of trochlear nerve schwannomas. Ophthalmology 2009; 116(10):2011-6.

6Clinical Challenges in Survey of Ophthalmology does not get indexed under the name of the physician who writes the discussion.

16

Frohman, LP

ARTICLES, cont...

73. Frohman L, Digre K. Elimination of consult codes in neuro-ophthalmology: another blow to our subspecialty? J Neuroophthalmol 2010; 30(2):210-1.

74. Pelegrin L. Mesquida M. Rey A. Sanchez-Dalmau B. Frohman LP. Clinical challenge: The blind runner (Takayasu’s arteritis). Surv Ophthalmol 2012Sep; 57(5):486-94

75. Chaudry A, Tekchand R, Frohman LP, Liu JK, Eloy A. Miller Fisher variant on Guillain-barre syndrome masquerading as acute sphenoid sinusitis with orbital apex syndrome. Laryngoscope 2012 May; 122(5):970-2.

76. Tannen BL, Kolomeyer AM, Turbin RE, Frohman L, Langer PD, Oh C, Ghesani NV, Zuckier LS, Chu DS. Lacrimal Gland Uptake of 67Ga-Gallium Citrate Correlates with Biopsy Results in Patients with Suspected Sarcoidosis. Ocul Immunol Inflamm 06/2013; DOI:10.3109/09273948.2013.791700

77. Kalyoussef E, Offor N, Quraishi H, Turbin, R, and Frohman LP. Idiopathic Intracranial Hypertension in a Child with Obstructive Sleep Apnea Cured by Tonsillectomy/Adenoidectomy. J. Neuro-ophthalmology, 2013 Dec;33(4):413-4.

78. Nayak NV, Frohman LP, Lambert WC, Langer PD. Postirradiation Periocular Granuloma Faciale Associated With Uveitis. Ophthal Plast Reconstr Surg. 2013 Nov 5. [Epub ahead of print]

79. Pinney EL, Ferreyra HA, Frohman L. Surv Ophthalmol. A curious case of glaucoma? Surv Ophthalmol. 2014 Mar-Apr;59(2):245-50

80. Simon, MA, Duffis EJ , Curi, MA, Turbin, RE, Prestigiacomo CJ, and Frohman, LP. Papilledema due to a permanent catheter for renal dialysis and an arteriovenous fistula: A "two hit" hypothesis. J Neuro-ophthalmology, 34:29-33; 2014

Peer Reviewed Articles as Part of a Study Group – Frohman L, Clinical Trial Participant

1. Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group The Idiopathic Intracranial Hypertension Treatment TrialThe Idiopathic Intracranial Hypertension Treatment Trial Clinical Profile at Baseline JAMA Neurol, (Published online April 21, 2014, In Press).

2. Wall M, NORDIC Idiopathic Intracranial Hypertension Study Group. Effect of Acetazolamide on Visual Function in Patients with Idiopathic Intracranial Hypertension and Mild Visual Loss: The Idiopathic Intracranial Hypertension Treatment Trial.  JAMA,. 2014;311(16):1641-1651

21. BOOKS, MONOGRAPHS and CHAPTERS7

1. Kupersmith M J, Weinberg H, Frohman LP, Warren F, Breinin GM. Ocular Myasthenia: Diagnosis and Treatment. In: Neuro-ophthalmology Enters the Nineties. Smith JL, Katz RS (eds). Dutton Press, Hialeah, FL, pp 173-182, 1988.

2. Mauriello, J, Wagner, R, Mostafavi, R, Frohman, L. Oculinum therapy: Its Use in Neuro-Ophthalmology. In: Neuro-ophthalmological Disorders: Diagnosis and Treatment, Tusa R, Newman SA (Ed); Marcel Decker, 1994, 451-478.

3. Frohman L, Bielory, L. Ocular and Neuro-ophthalmic Vasculitis. Advances in Clinical Ophthalmology, Volume 2, Burde RM , Slamovits TL ( eds). Mosby, St Louis, 1995.

4. Frohman, L. Skuta G (ed). PROVISION, ed 2., Neuro-ophthalmology Section. American Academy of Ophthalmology, San Francisco, 1995

5. Frohman L, Warren F, Wisnicki J, Johnson C, Rapuano C. Interactive Provision Interactive (CD-ROM). Volume 1 American Academy of Ophthalmology, San Francisco, 1996.

6. Frohman, L (ed). Provision Interactive (CD-ROM). Volume 2. American Academy of Ophthalmology, 1997.7. Frohman L, Lee A. The American Academy of Ophthalmology/North American Neuro-Ophthalmology Interactive Clinical

Case Slide Atlas of Neuro-ophthalmology (CD-ROM), American Academy of Ophthalmology, 1998.8. Frohman L, Warren F. Skuta G (ed). PROVISION, ed 3., Neuro-ophthalmology Section. American Academy of

Ophthalmology, 1998.9. Frohman L. Other Inflammatory Optic Neuropathies. In: Levin LA , Arnold AC (eds), Neuro-ophthalmology The Practical

Guide. Thieme Publishers, New York, NY, 2005; pp 202-216.10. Frohman, LP. Scleroderma. In: Roy & Fraunfelder (eds), Current Ocular Therapy, 6th ed. Elsevier 2007.

7Includes peer- reviewed, nationally published CD-ROM texts.

17

Frohman, LP

11. Frohman, LP. Do Refractive Errors Cause Headaches? Curbside Consultation in Pediatric Ophthalmology Slack, Inc., (In press).

12. Frohman, L. Do Refractive Errors Cause Headaches? (Section VI – Question 31) In: Wagner RS (ed). Curbside Consultation in Pediatric Ophthalmology: 49 Clinical Questions. Thorofare, NJ, Slack Inc., 2014:155-7

13.22. ABSTRACTS- upon request

23. REVIEWS

1. Selected reviewer, American Academy of Ophthalmology, Preferred Physicians Response in Ophthalmology CME Series, Neuro-ophthalmology Section, 1992.

24. REPORTS

1. Ebrahim B, Frohman LP, Zarbin MA, Bhagat N. Tonic pupil following pars plana vitrectomy and endolaser. Case Reports in Medicine accessed at http://www.hindawi.com/ journals/crm/ 2009/970502.html, Volume 2009 (2009), Article ID 970502, 3 pages.

25. PATENTS HELDNone

18

Frohman, LP

APPENDIX A:

INVITED SPEAKER - NATIONAL/ INTERNATIONAL MEETINGS

INTERNATIONAL 1. Ischemic Optic Neuropathy. Coimbra University, Coimbra, Portugal, May 31, 2000.2. Ischemic Optic Neuropathy. Gamma Pinto Eye Institute, Lisbon, Portugal, June 1, 2000.3. Optic Neuritis. Gamma Pinto Eye Institute, Lisbon, Portugal, June 1, 2000.4. Ocular Sarcoidosis. Gamma Pinto Eye Institute, Lisbon, Portugal, June 2, 2000.5. Frohman L, Turbin R, Bielory L, Cook S. She’s Only 8, Should She See the ABC’S. CD-ROM: Presented at the 33rd

Frank B. Walsh Annual Meeting of the 27th Annual North American Neuro-Ophthalmology Society (NANOS). Rancho Mirage, CA, February 18, 2001.

6. Frohman LP, Wolansky L, Turbin RE, Lambert WC, Bielory L, Cook SD. She’s Only 8, Should She See the ABC’s ? (Antiphospholipid antibody syndrome mimicking MS in an 8 year old). North American Neuro-ophthalmology Society Meeting, Ann Arbor, MI, April, 2001.

7. Turbin RE, Frohman LP, Facciani J, Carmel P, Lee HJ, Wolansky L, Chu L. Rare, That's an Understatement. CD-ROM: Presented at the 34th Frank B. Walsh Annual Session of the 28th Annual North American Neuro-Ophthalmology Society (NANOS). Copper Mountain, CO, February 16, 2002.

8. Turbin R, Frohman L, Carmel P, Prasad A, Sharer L, Wolansky L. Case 5: Can You Remember Another Triad. CD-ROM: Presented at the 35th Frank B. Walsh Annual Session of the 29th Annual North American Neuro-Ophthalmology Society (NANOS). Snowbird, Utah February 9, 2003.

9. Turbin RE, Frohman LP, Farkas J, Mirani N, Cuadra S, and Padberg F. When All Else Fails, Lay on Hands. CD-ROM: Presented at the 37th Annual Frank B. Walsh Session. 31st Annual meeting North American Neuro-ophthalmology Society, Copper Mountain, CO, February 13, 2005.

10. Larry Frohman. Autoimmune Optic Neuropathy. North American Neuro-ophthalmology Society, Snowbird, UT, February 15, 2007

11. Kathleen Digre, Nancy Lombardo, Larry Frohman. The Neuro-ophthalmology Illustrated Curriculum. [poster] European Neuro-ophthalmology Society (EUNOS) Meeting, Istanbul, Turkey, May 26-29, 2007.

12. Kim HJ, Wenzhuan He, Chu D, Frohman LP, Langer P, Turbin RE. Correlation of histologic changes in lacrimal and salivary glands to gallium and MRI findings in sarcoid suspects. Poster. Presented at the International Ocular Inflammation Society, Prague, Czech Republic, June 2009.

13. Pham M, Lee H-J, Turbin R, Frohman L. Does Lacrimal Gland Size on MRI Scans Differentiate Sarcoid From Demyelinating Optic Neuritis. NANOS 2011 Annual Meeting, Vancouver, BC, Canada, February 8, 2011.

14. Elenein RA, Frohman L, Turbin R. Visual Outcome of Unaffected Eye in Idiopathic Intracranial Hypertension with Unilateral Papilledema. NANOS 2011 Annual Meeting, Vancouver, BC, Canada, February 8, 2011.

15. Elenein R, Frohman L, Turbin R, Vasudev D. Analysis of Therapeutic Agents and their Effectiveness in Sarcoid Optic Neuropathy. NANOS 2012 Annual Meeting, San Antonio, TX, February 14, 2012.

16. Frohman L. Therapy of Neuro/Neuro-Ophthalmic Sarcoid. NANOS Annual Meeting, Snowbird, UT, February 11, 2013.

17. Frohman, Larry. Myths About Giant Cell Arteritis. Neuro-ophthalmology Society of Australia. Noosa, Queensland, Australia, 9/5-9/6/13.

18. Frohman, Larry. Autoimmune Optic Neuropathy. Neuro-ophthalmology Society of Australia. Noosa, Queensland, Australia, 9/5-9/6/13.

19. Frohman, Larry. Diagnosis and Treatment of Sarcoid Optic Neuropathy. Neuro-ophthalmology Society of Australia. Noosa, Queensland, Australia, 9/5-9/6/13.

20. Frohman, Larry. Politics of Neuro-ophthalmology NeuroVision Training Weekend. Noosa, Queensland, Australia, 9/7/13

21. Frohman, Larry. Non-Arteritic Ischemic Optic Neuropathy NeuroVision Training Weekend. Noosa, Queensland, Australia, 9/7/13.

22. Frohman, Larry. Neuro-ophthalmic Manifestations of Vasculitis. NeuroVision Training Weekend. Noosa, Queensland, Australia, 9/7/13.

19

Frohman, LP

NATIONAL1. Berman, Eric, Kaufmann, David, Frohman, Larry, et al. Skills Transfer Course: Neuroimaging in Ophthalmology.

Course at American Academy of Ophthalmology, Dallas, October,2000.2. Chosen Platform reviewer for Chiari I Malformation Mimicking Pseudotumor Cerebri: neuroimaging and treatment,

American Academy of Ophthalmology, Dallas, October, 2000.3. Frohman, LP. Neuro-ophthalmic Sarcoidosis. National Sarcoidosis Resource Center, New Jersey January 28, 2000.4. Berman, Eric, Kaufmann, David, Frohman, Larry, et al. Skills Transfer Course: Neuroimaging in Ophthalmology.

Course at American Academy of Ophthalmology, New Orleans, November, 2001.5. Medical Therapy of Pseudotumor Cerebri American Academy of Ophthalmology Subspecialty Day, New Orleans,

November 10, 2001. 6. Update in Neuro-ophthalmology. Rush Memorial Hospital, Chicago, IL.7. Visiting Professor in Neuro-ophthalmology, Departments of Ophthalmology and Neurosciences, Michigan State

University, 10/3-10/4/02.8. Grand Rounds, Sarcoidosis, Hershey-Penn State Medical School, October 9, 2002.9. Berman, Eric, Kaufmann, David, Frohman, Larry, et al. Skills Transfer Course: Neuroimaging in Ophthalmology.

Course at American Academy of Ophthalmology, Orlando, FL, November, 2002.10. Frohman LP. Atypical Optic Neuropathy. American Academy of Ophthalmology Annual Subspecialty Day, Anaheim,

CA, November 15, 200311. Frohman L , Baldo L. Implementation of a Wireless Charge Capture/Compliance System- The UPA Experience

Capture/Compliance System- The UPA Experience Medical Group Management Association- Academic Practice Assembly Annual Meeting. Seattle Washington, May 4, 2004.

12. Larry Frohman. Atypical Optic Neuritis. American Academy of Ophthalmology Subspecialty Day, Chicago, IL, October 15, 2005.

13. Larry Frohman. Optic Neuritis. Breakfast Course. American Academy of Ophthalmology, Chicago, IL, October 16, 2005.

14. Larry Frohman. Optic Neuritis. Breakfast Course. American Academy of Ophthalmology, Chicago, IL, October 17, 2005.

15. Larry Frohman. Sarcoidosis of the Anterior Visual System. Grand Rounds, Department of Ophthalmology, NY Medical College, December 5, 2006

16. Larry Frohman. Underrepresented Specialties. Association of University Professors of Ophthalmology, Sarasota, FL, January 31, 2008.

17. Larry Frohman. Neuro-ophthalmology Virtual Education Library (NOVEL) Project. Poster presentation, International Neuro-ophthalmology Society Annual Meeting, San Francisco, CA, June 9-12, 2008.

18. Larry Frohman. Autoimmune Visual Loss. Combined Ophthalmology Residency Lecture Series, Washington National Eye Center, Washington DC, December 6, 2008.

19. Larry Frohman. Neuro-Ophthalmology Virtual Education Library: 2009 NOVEL Update. [poster] 35th Annual North American Neuro-Ophthalmology Society Meeting, Lake Tahoe, NV, February 24, 2009.

20. Kim HJ, He W, Chu D, Mirani N, Frohman LP, Langer P, Turbin RE. Correlation of histologic changes in lacrimal and salivary glands to gallium and MRI findings in sarcoid suspects. Poster presentation at the American Society of Oculoplastic & Reconstructive Surgery (ASOPRS). October 2009.

21. Frohman L, Associate Instructor. Neuroimaging in Ophthalmology (LAB192). 2009 Joint Meeting of the American Academy of Ophthalmology and the Pan-American Association of Ophthalmology, San Francisco, CA, October 25, 2009.

22. Frohman LP. Autoimmune Optic Neuropathy. Pittsburgh Ophthalmology Club, Pittsburgh, PA, December 2010.23. Frohman LP. Update on a Common Neuro-ophthalmic Disorder We Thought We Knew. Pittsburgh Ophthalmology

Club, Pittsburgh, PA, December 2010.24. Frohman LP. Sarcoidosis of the Anterior Visual Pathway. Pittsburgh Ophthalmology Club, Pittsburgh, PA,

December 2010.25. Frohman LP. Panelist, Neuro-ophthalmology Subspecialty Day, Annual Meeting of the American Academy of

Ophthalmology, Orlando, FL, October 22, 2011.26. Frohman LP. Optic Neuritis and Multiple Sclerosis. Breakfast Round Table, Annual Meeting of the American

Academy of Ophthalmology, Orlando, FL, October 22, 2011.

20

Frohman, LP

27. Frohman LP. Neuro-ophthalmology Imaging Skills Transfer Course. Annual Meeting of the American Academy of Ophthalmology, Orlando, FL, October 22, 2011.

NATIONAL, cont... 28. Chaudhary A, Ramchand T, Frohman LP, Liu JK, Eloy JA. Miller Fisher Variant of Guillain Barre Syundrome

Masquerading as Acute Sphenoid Sinusitis with Orbital Apex Syndrome. Combined Sections Meeting of The Triological Society, Miami Beach, FL, January 2012.

29. Frohman L. Current and Emerging Concepts of Giant Cell Arteritis. Breakfast with the Experts Roundtable Program, American Academy of Ophthalmology Annual Meeting, Chicago, IL, November 2012.

30. Gliddon C, et. al….Frohman L. Skills Transfer Course in Neuroimaging. American Academy of Ophthalmology Annual Meeting, Chicago, IL, November 13, 2012.

31. Larry Frohman, MD Update in a Disease We thought We Knew. Comprehensive Ophthalmology Pearls XVII, Vanderbilt University, April 4, 2014

32. Larry Frohman, MD Neuro-ophthalmic Sarcoidosis: Diagnostic and Therapeutic Considerations Comprehensive Ophthalmology Pearls XVII, Vanderbilt University, April 4, 2014

21

Frohman, LP22